142 related articles for article (PubMed ID: 16554018)
1. Mannan-binding lectin-associated serine protease 3 cleaves synthetic peptides and insulin-like growth factor-binding protein 5.
Cortesio CL; Jiang W
Arch Biochem Biophys; 2006 May; 449(1-2):164-70. PubMed ID: 16554018
[TBL] [Abstract][Full Text] [Related]
2. MASP-1, a promiscuous complement protease: structure of its catalytic region reveals the basis of its broad specificity.
Dobó J; Harmat V; Beinrohr L; Sebestyén E; Závodszky P; Gál P
J Immunol; 2009 Jul; 183(2):1207-14. PubMed ID: 19564340
[TBL] [Abstract][Full Text] [Related]
3. The structure of MBL-associated serine protease-2 reveals that identical substrate specificities of C1s and MASP-2 are realized through different sets of enzyme-substrate interactions.
Harmat V; Gál P; Kardos J; Szilágyi K; Ambrus G; Végh B; Náray-Szabó G; Závodszky P
J Mol Biol; 2004 Oct; 342(5):1533-46. PubMed ID: 15364579
[TBL] [Abstract][Full Text] [Related]
4. Elucidation of the substrate specificity of the MASP-2 protease of the lectin complement pathway and identification of the enzyme as a major physiological target of the serpin, C1-inhibitor.
Kerr FK; Thomas AR; Wijeyewickrema LC; Whisstock JC; Boyd SE; Kaiserman D; Matthews AY; Bird PI; Thielens NM; Rossi V; Pike RN
Mol Immunol; 2008 Feb; 45(3):670-7. PubMed ID: 17709141
[TBL] [Abstract][Full Text] [Related]
5. Quantitative characterization of the activation steps of mannan-binding lectin (MBL)-associated serine proteases (MASPs) points to the central role of MASP-1 in the initiation of the complement lectin pathway.
Megyeri M; Harmat V; Major B; Végh Á; Balczer J; Héja D; Szilágyi K; Datz D; Pál G; Závodszky P; Gál P; Dobó J
J Biol Chem; 2013 Mar; 288(13):8922-34. PubMed ID: 23386610
[TBL] [Abstract][Full Text] [Related]
6. Selective inhibition of the lectin pathway of complement with phage display selected peptides against mannose-binding lectin-associated serine protease (MASP)-1 and -2: significant contribution of MASP-1 to lectin pathway activation.
Kocsis A; Kékesi KA; Szász R; Végh BM; Balczer J; Dobó J; Závodszky P; Gál P; Pál G
J Immunol; 2010 Oct; 185(7):4169-78. PubMed ID: 20817870
[TBL] [Abstract][Full Text] [Related]
7. Production and purification of recombinants of mouse MASP-2 and sMAP.
Iwaki D; Fujita T
J Endotoxin Res; 2005; 11(1):47-50. PubMed ID: 15826378
[TBL] [Abstract][Full Text] [Related]
8. Cooperation between MASP-1 and MASP-2 in the generation of C3 convertase through the MBL pathway.
Møller-Kristensen M; Thiel S; Sjöholm A; Matsushita M; Jensenius JC
Int Immunol; 2007 Feb; 19(2):141-9. PubMed ID: 17182967
[TBL] [Abstract][Full Text] [Related]
9. Murine serine proteases MASP-1 and MASP-3, components of the lectin pathway activation complex of complement, are encoded by a single structural gene.
Stover CM; Lynch NJ; Dahl MR; Hanson S; Takahashi M; Frankenberger M; Ziegler-Heitbrock L; Eperon I; Thiel S; Schwaeble WJ
Genes Immun; 2003 Jul; 4(5):374-84. PubMed ID: 12847554
[TBL] [Abstract][Full Text] [Related]
10. Two lineages of mannose-binding lectin-associated serine protease (MASP) in vertebrates.
Endo Y; Takahashi M; Nakao M; Saiga H; Sekine H; Matsushita M; Nonaka M; Fujita T
J Immunol; 1998 Nov; 161(9):4924-30. PubMed ID: 9794427
[TBL] [Abstract][Full Text] [Related]
11. Mannan-binding lectin-associated serine protease-2 (MASP-2) in a large cohort of neonates and its clinical associations.
St Swierzko A; Cedzynski M; Domzalska-Popadiuk I; MacDonald SL; Borkowska-Klos M; Atkinson AP; Szala A; Jopek A; Jensenius JC; Kawakami M; Szczapa J; Matsushita M; Szemraj J; Turner ML; Kilpatrick DC
Mol Immunol; 2009 May; 46(8-9):1696-701. PubMed ID: 19307021
[TBL] [Abstract][Full Text] [Related]
12. Natural substrates and inhibitors of mannan-binding lectin-associated serine protease-1 and -2: a study on recombinant catalytic fragments.
Ambrus G; Gál P; Kojima M; Szilágyi K; Balczer J; Antal J; Gráf L; Laich A; Moffatt BE; Schwaeble W; Sim RB; Závodszky P
J Immunol; 2003 Feb; 170(3):1374-82. PubMed ID: 12538697
[TBL] [Abstract][Full Text] [Related]
13. Heterogeneity of MBL-MASP complexes.
Mayilyan KR; Presanis JS; Arnold JN; Hajela K; Sim RB
Mol Immunol; 2006 Mar; 43(8):1286-92. PubMed ID: 16102832
[TBL] [Abstract][Full Text] [Related]
14. Localization and characterization of the mannose-binding lectin (MBL)-associated-serine protease-2 binding site in rat ficolin-A: equivalent binding sites within the collagenous domains of MBLs and ficolins.
Girija UV; Dodds AW; Roscher S; Reid KB; Wallis R
J Immunol; 2007 Jul; 179(1):455-62. PubMed ID: 17579066
[TBL] [Abstract][Full Text] [Related]
15. The mannan-binding lectin pathway and lung disease in cystic fibrosis--disfunction of mannan-binding lectin-associated serine protease 2 (MASP-2) may be a major modifier.
Olesen HV; Jensenius JC; Steffensen R; Thiel S; Schiøtz PO
Clin Immunol; 2006 Dec; 121(3):324-31. PubMed ID: 17045845
[TBL] [Abstract][Full Text] [Related]
16. The chaperone and potential mannan-binding lectin (MBL) co-receptor calreticulin interacts with MBL through the binding site for MBL-associated serine proteases.
Pagh R; Duus K; Laursen I; Hansen PR; Mangor J; Thielens N; Arlaud GJ; Kongerslev L; Højrup P; Houen G
FEBS J; 2008 Feb; 275(3):515-26. PubMed ID: 18177377
[TBL] [Abstract][Full Text] [Related]
17. Genetic influences on mannan-binding lectin (MBL) and mannan-binding lectin associated serine protease-2 (MASP-2) activity.
Sorensen GL; Petersen I; Thiel S; Fenger M; Christensen K; Kyvik KO; Sørensen TI; Holmskov U; Jensenius JC
Genet Epidemiol; 2007 Jan; 31(1):31-41. PubMed ID: 17096357
[TBL] [Abstract][Full Text] [Related]
18. Differential substrate and inhibitor profiles for human MASP-1 and MASP-2.
Presanis JS; Hajela K; Ambrus G; Gál P; Sim RB
Mol Immunol; 2004 Feb; 40(13):921-9. PubMed ID: 14725788
[TBL] [Abstract][Full Text] [Related]
19. A novel mannose-binding lectin-associated serine protease 1/3 gene variant.
Weiss G; Madsen HO; Garred P
Scand J Immunol; 2007 May; 65(5):430-4. PubMed ID: 17444953
[TBL] [Abstract][Full Text] [Related]
20. Complement protease MASP-1 activates human endothelial cells: PAR4 activation is a link between complement and endothelial function.
Megyeri M; Makó V; Beinrohr L; Doleschall Z; Prohászka Z; Cervenak L; Závodszky P; Gál P
J Immunol; 2009 Sep; 183(5):3409-16. PubMed ID: 19667088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
